Clinical Trial Update: Efficacy and Safety of SPD465 in Adults With ADHD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating SPD465 for efficacy and safety in adults with ADHD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Disorder with Hyperactivity

Drugs mentioned

• SPD465

Snippet

Sponsor: Shire | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 3 | Status: COMPLETED